Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002448.SZ
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 7.42 1.61 1.50
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -52.74 4.07 8.61
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 1.96 5.80 5.69
Cash 10.05 0.98 0.89
Capex -14.13 -0.03 -0.02
Free Cash Flow -38.49 0.06 0.10
Revenue 4.70 1.41 1.35
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 12.16 0.26 0.23
Operating Margin 101.29 0.13 0.06
ROA 77.22 0.02 < 0.005
ROE 74.36 0.03 0.01
ROIC 83.72 0.02 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002448.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002448.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002448.SZ is permitted for members.